Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function. - Wikidata - awgldk - TriplyDB

Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.

Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.

http://www.wikidata.org/entity/Q33385520

about

Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers.Biology and chemistry of thrombopoietic agents Neonatal thrombocytopenia and megakaryocytopoiesis.Toxicities of the thrombopoietic growth factors Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.Thrombopoietin receptor levels in tumor cell lines and primary tumors Platelet activation and function during eltrombopag treatment in immune thrombocytopenia.Management of immune thrombocytopenic purpura in children: potential role of novel agents.In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.Eltrombopag in patients with chronic liver disease.Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.The biology of thrombopoietin and thrombopoietin receptor agonists.Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study The pharmacology and clinical application of thrombopoietin receptor agonists.Eltrombopag: a review of its use in the treatment of thrombocytopenia in patients with chronic hepatitis C.The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.Novel functions of platelets in the liver.Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia.Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals.Platelets in liver disease, cancer and regeneration A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis Eltrombopag: a review of its use in patients with severe aplastic anaemia.Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells.Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphisms.Extensive cerebral venous sinus thrombosis following a dose increase in eltrombopag in a patient with idiopathic thrombocytopenic purpura.Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review.Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis.Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis.Phenotype description and response to thrombopoietin receptor agonist in -related disorder

P2860

Q33387808-B2C83BD6-70BC-4E37-A1DF-1CD3894635A7 Q33389236-8441723F-27B5-4745-8EFB-E882BC2E9C7B Q33389284-3A1A1B99-A94B-4184-B2D9-95D8F93E81BC Q33390625-3189C07D-6A33-4206-A480-59C4DC9AD062 Q33390642-3FF7541B-748F-4D2A-9659-D847A271C091 Q33390645-DB345D62-FD64-46A3-B86A-1C7DF567EB32 Q33391229-3894396F-1730-405C-966E-00BA666D052E Q33394052-0C15680E-D0BA-428D-9AFD-45F0A9CD8B4E Q33394117-ADB50B26-AB71-4EFC-8336-4E9B5D7E93FB Q33395231-7059F836-6944-4A8A-B56A-F8E2B3DB5575 Q33395863-90BE212D-9030-4931-B67B-C8664B51B2F2 Q33399437-0F5D3741-90AC-4670-BFB8-72ADB2B1D49D Q33403234-9454A054-73E4-4279-B79F-F7A6E28B8043 Q33406181-674D8474-DD1B-4ACB-81F6-2A0532F3CC20 Q33406819-8FC83975-35C1-40B2-B2AE-5B762418FF21 Q33407110-14252FD0-DE8D-4887-AEB4-09A5195C9D3C Q33408850-7BC770A2-7186-45FD-91FF-689CF9E67CE9 Q33411387-4F93D024-7F07-4B3C-9474-BCE10F7961C5 Q33414386-57F64766-FE1A-4CD0-B439-616C06F6FE3F Q33417148-82ACFFBF-98FF-4C77-9A8D-A72F97A294A3 Q33417372-D18639D0-EA7F-4978-8E6B-53E46EED5846 Q33417700-9E79A94B-0DB4-438D-9F62-94ADF636BCEC Q33418303-3FCD4B59-E521-4C3D-A803-D36DE6A36BA1 Q33422127-9C0EAC8D-B536-4199-BF83-2B712C635173 Q33425628-E32E4CFC-54CB-4437-9F28-439E2E521E1C Q33428110-6C63D496-542D-46FF-AC27-FFEDC436A006 Q33432023-C0D1C692-8EC9-4ABA-A5B8-FB61970E3E75 Q33442131-821AD74D-C678-4488-AD7B-77A5F563E51F Q33442308-77A1F476-0069-478B-9C85-505322DB3E48 Q35683792-005D5EB6-9332-41B0-AB26-734CF5888E8D Q36144024-1E800204-9CA0-485C-B4AE-AA57F3F22BC7 Q38363139-123BEF59-69DC-4A7B-9183-1D80E6146DA0 Q38731503-05E85B74-4198-4CD4-A973-27E9D6676BA6 Q44217288-75DD2C68-4E18-4C2F-8100-906B2760FE42 Q44713760-943039C1-2865-4E65-A88E-CDE06F2B914C Q47898156-491EF689-1E35-43B9-9BF7-3E51CFAD6598 Q48320457-7BE6CC11-A0D7-49E8-89FB-8C84B215A2C1 Q49534414-676D9A66-8AAD-4DD4-9C44-E7413B4ACF57 Q55424728-F1727053-D977-46A3-97B6-8580A21F78E8 Q58717272-7F982CBE-74CD-49D1-911A-33036A22A6FC

P2860

Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.

http://www.wikidata.org/entity/Q33385520

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Comparative analyses of the sm ...... on in vitro platelet function.

@ast

Comparative analyses of the sm ...... on in vitro platelet function.

@en

type

label

Comparative analyses of the sm ...... on in vitro platelet function.

@ast

Comparative analyses of the sm ...... on in vitro platelet function.

@en

prefLabel

Comparative analyses of the sm ...... on in vitro platelet function.

@ast

Comparative analyses of the sm ...... on in vitro platelet function.

@en

P1433

Q33385520-B3FDADC0-4F0E-4756-8F13-54EBF8BDE242

P1476

Q33385520-14952AE5-21F1-46D4-90F4-84D4B720AE8F

P2093

Q33385520-05B4FEA5-23B5-4F0B-8FD3-808C342837FD

Q33385520-18DA6A54-8D41-42F8-B3A2-FC8C8ACCAD0D

Q33385520-407E9791-69E7-40B7-8C2F-10E9FA5BB47E

Q33385520-A5A1695B-63EA-4119-9CBD-1651CEDCE052

Q33385520-DB922CF2-66CD-4A60-8D3D-8750EEF9D41A

Q33385520-EC1258BC-241C-4D6D-8E8C-1CA725DBF327

P304

Q33385520-004683D4-21FC-494B-87E1-5471DBFE7F3A

P31

Q33385520-8D579DA5-B0A8-4989-A41E-D40E057EFB43

P356

Q33385520-5FD6D967-6561-41F7-A04A-1994FBA915CA

P433

Q33385520-F91126D1-F998-4010-AB69-D346C1F9335F

P478

Q33385520-DAD3A1FB-43C2-4BCB-9ADC-916E82776120

P577

Q33385520-88D7EBB7-668B-4C5B-8C18-1BEAD669B0A0

P698

Q33385520-6611FDDB-B157-4C85-AA65-DF0920BB5084

P356

J.EXPHEM.2009.06.011

P1433

Experimental Hematology

P1476

Comparative analyses of the sm ...... on in vitro platelet function.

@en

P2093

Connie L Erickson-Miller

http://www.w3.org/2001/XMLSchema#string

John R Toomey

http://www.w3.org/2001/XMLSchema#string

Joseph A Erhardt

http://www.w3.org/2001/XMLSchema#string

Kodandaram Pillarisetti

http://www.w3.org/2001/XMLSchema#string

Manuel Aivado

http://www.w3.org/2001/XMLSchema#string

Melanie Abboud

http://www.w3.org/2001/XMLSchema#string

P304

1030-1037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPHEM.2009.06.011

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19631713

http://www.w3.org/2001/XMLSchema#string